Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-30 4:11 pm Sale |
2022-12-27 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 463,143 4.600% |
-200,000 (-30.16%) |
Filing History |
| 2022-02-14 09:08 am Sale |
2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Sonic Fund II L.P. | 2,469,880 9.500% |
-25,873 (-1.04%) |
Filing History |
| 2021-04-16 3:11 pm Unchanged |
2021-04-15 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 663,143 6.800% |
0 (Unchanged) |
Filing History |
| 2021-04-09 4:54 pm Purchase |
2021-03-24 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 663,143 6.800% |
50,000 (+8.15%) |
Filing History |
| 2021-03-18 2:21 pm Purchase |
2021-03-15 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 613,143 6.300% |
91,528 (+17.55%) |
Filing History |
| 2021-02-16 3:46 pm Purchase |
2020-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 521,615 5.400% |
96,887 (+22.81%) |
Filing History |
| 2021-02-16 3:44 pm Purchase |
2020-04-30 | 13G | Fennec Pharmaceuticals Inc. FENC |
Sonic Fund II L.P. | 2,495,753 9.700% |
2,495,753 (New Position) |
Filing History |
| 2020-08-20 2:21 pm Purchase |
2020-08-18 | 13D | Adverum Biotechnologies, Inc. ADVM |
Sonic Fund II L.P. | 424,728 4.400% |
45,172 (+11.90%) |
Filing History |